Today, too many never get one in time: fewer than 5% of new cancer drugs make it through clinical trials and every failure costs patients years.
Orakl exists to change those odds.
We bridge biological and artificial intelligence by building large cohorts of virtual cancer patients: real patients’ tumors, paired with their medical history and deep biological data.
Because we can test treatments on these virtual patients at scale, we can predict, with causal evidence, how a patient will respond to a drug long before it reaches the clinic.
This helps pharma companies bet on the right drugs, for the right patients, much earlier on.
We were founded in 2023 by Fanny Jaulin, PhD, Diane-Laure Pagès and Gustave Ronteix, PhD as a spin-out from Gustave Roussy, one of Europe’s leading cancer centers, and we build on 10 years of research.
We are backed by top international VCs and growing fast.
Discover more here on Orakl’s website.
The roleOrakl is looking for a Senior Business Development Manager to build and run its partnership pipeline with pharma and biotech.
You will find the right accounts, reach the right people inside them and turn first conversations into qualified opportunities for the VP Business Development.
You will own the front end of Orakl’s commercial engine: account strategy, prospecting, discovery and pipeline discipline.
You will work closely with the VP BD, the Product Marketer, the scientific teams and the founders, and alongside the Communications & Events Lead on conferences.
Prospects: target, position, engageDefine where Orakl plays.
Identify and prioritise the pharma and biotech accounts where Orakl’s offerings create the most value, based on their oncology pipelines and development stage.
Position Orakl’s offer.
Tailor Orakl’s value proposition to each account’s programmes, priorities and decision makers.
Open new relationships.
Engage decision makers at target accounts t.